Market outlook to 2032: future trends across the seven major markets
European Pharmaceutical Review
JANUARY 18, 2024
“The dominance of the US within the 7MM is due to its larger insomnia population and higher drug prices. GlobalData considered drug pricing and market exclusivity to be two major obstacles. GlobalData considered drug pricing and market exclusivity to be two major obstacles.
Let's personalize your content